Answers are grounded in this paper and cite their sources.
Background: Dry eye disease is a condition that affects millions of people around the world. The use of autologous serum is suggested as part of the treatment with moderate-severe disease degree. With this systematic review we aim to evaluate the effectivity and safety of autologous serum for dry eye disease. Methods: Electronic bases will be searched; we will include randomized controlled trials to compare autologous serum with artificial tears. Study inclusion will not be restricted on the basis of language or publication status. Identification, evaluation, data extraction and assessment of risk of bias will be conducted by two authors of the review, a third review author will resolve any disagreement. The outcomes will be the ocular surface disease index score, osmolarity and tear film break-up time. We will use the Cochrane Collaboration Risk of Bias 2 for assessing the risk of bias in included studies. Based on the heterogeneity of the included studies, we will consider combining our findings in a meta-analysis. Results: Based on the evidence obtained we will evaluate the effect of autologous serum and artificial tears on multiple outcome measures. Conclusion: The aim of this systematic review is to determine the efficacy and safety of autologous serum for the treatment of dry eye and help clinicians in the decision-making process.
No takes yet. Share an insight, caveat, or question.
Pérez-Vázquez et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: